Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Vetter Invests €500 Million to Expand New Saarlouis Injectable Drug Manufacturing Facility
Vetter has started construction of its new pharmaceutical manufacturing facility in Saarlouis, Germany, supported by an investment of nearly 500 million The project will expand the companys commercial manufacturing capabilities for injectable medicines and support increasing global demand for complex drug products
Novartis Invests $23 Billion to Expand New Texas Radioligand Therapy Facility
Novartis has started construction on a new 46,000 sq ft radioligand therapy RLT manufacturing facility in Denton, Texas, as part of its wider $23 billion investment programme in the United States
Amgen Announces Additional $300 Million to Expand Puerto Rico Manufacturing Operations
Amgen has announced an additional investment of $300 million to expand its manufacturing operations in Puerto Rico The latest investment brings Amgens recently announced commitments in Puerto Rico to nearly $1 billion
PCI Pharma Services Expands Global Manufacturing Network with $1B+ Investment in San Diego
PCI Pharma Services has announced an investment programme exceeding $1 billion across its US and European operations to strengthen sterile fillfinish and advanced drug delivery capabilities
Novartis Announces $23 Billion Investment to Expand API Manufacturing Facility in North Carolina
Novartis has announced plans to develop a new 56,200squarefoot manufacturing facility in Morrisville, North Carolina, as part of its wider $23 billion investment in USbased manufacturing and research
Cambrex Announces $150 Million Expansion across U.S. and European Facilities
Cambrex has revealed significant progress on its expansion initiatives across the United States and Europe These projects are designed to boost capacity for manufacturing complex drugs
Axplora Invests $60 Million to Expand High-Potency Drug Manufacturing Capacity
Axplora has announced a major expansion of its manufacturing and research capabilities in response to the growing demand for highly potent drugs The development will take place at its Farmabios site
CSL to Invest $1.5 Billion in Expansion of Illinois Plasma Therapy Facility
CSL has announced a $15 billion expansion of its manufacturing facility The expansion will significantly increase production of plasmaderived therapies and albumin
Johnson & Johnson Invests Over $1 Billion in New Cell Therapy Manufacturing Facility
Johnson Johnson has announced plans to invest more than $1 billion in a nextgeneration cell therapy manufacturing facility in Montgomery County, Pennsylvania The new site will expand the companys manufacturing capacity
AbbVie Announces $380 Million Expansion of API Manufacturing in North Chicago
AbbVie has revealed plans to invest $380 million to expand its active pharmaceutical ingredient API production capabilities at its North Chicago campus The initiative involves constructing
